(Q47448168)

English

Pharmacodynamic properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects

scientific article published in July 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

Pharmacodynamic properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

human subject research project

0 references

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Shaker A Mousa

1

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

Jeffrey Bozarth

2

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

Jeffrey S Barrett

3

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

43

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

7

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

727-734

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

Tissue factor expression and angiogenesis in human glioma

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Effect of antihemostatic agents on experimental tumor dissemination

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Anticoagulants in thrombosis and cancer: the missing link

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Comparative pharmacokinetics of LMWHs

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Effect of heparin chain length on the interaction with tissue factor pathway inhibitor (TFPI).

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Low-molecular-weight heparin in the treatment of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Anticoagulant pharmacodynamics of tinzaparin following 175 iu/kg subcutaneous administration to healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Tissue factor and angiogenesis in cancer

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

The effect of molecular weight on the bioavailability of heparin

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Pharmacokinetic and pharmacodynamic characterization of a medium-molecular-weight heparin in comparison with UFH and LMWH.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Tissue factor pathway inhibitor (TFPI)--an update

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Differential expression of tissue factor and tissue factor pathway inhibitor in metastatic melanoma lesions

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

The low molecular weight heparin, tinzaparin, in thrombosis and beyond.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Elevated plasma levels of the factor Xa-TFPI complex in cancer patients

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Anti-inflammatory effects of long-lasting locally-delivered human recombinant tissue factor pathway inhibitor after balloon angioplasty

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Effect of repeated Aprosulate?? and Enoxaparin?? administration on tissue factor pathway inhibitor antigen levels

1 reference

https://api.crossref.org/works/10.1177%2F0091270003254793

21 January 2018

Identifiers

10.1177/0091270003254793

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 January 2018

http://europepmc.org/abstract/MED/12856386

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47448168&oldid=2158493879"